查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1667687

2025 年全球药物涂层球囊市场

Drug-Coated Balloons Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年药物涂层球囊市场将快速成长。预计到 2029 年将以 15.6% 的复合年增长率成长，达到 22.2 亿美元。

预测期内成长的主要驱动力包括老年人口的成长、适应症和用途的扩大、对门诊和门诊护理的关注度增加、与药物输送创新的结合以及全球健康倡议。预测期内的关键趋势包括新配方的监管核准、注重减少副作用、生物可吸收涂层的出现、新兴国家的市场扩张以及以患者为中心的方法。

冠状动脉疾病（CAD）盛行率的不断上升预计将在未来几年推动药物涂层球囊市场的成长。药物涂层球囊是用于治疗 CAD 的医疗设备，可在手术过程中将药物释放到动脉中，以防止再狭窄（血管成形术后动脉血管再阻塞）。根据 2022 年 8 月发表在《美国心臟病学会杂誌》上的一项研究，预计 2025 年至 2060 年期间美国普通人群的所有四种心血管风险因素都将增加。预测增幅最大的是糖尿病，为39.3%；其次为血脂异常症，为27.6%；高血压，为25.1%；肥胖，为18.3%。此外，心臟衰竭（33.4%）和缺血性心臟疾病（30.7%）的发病率预计将增加最大，心肌梗塞（16.9%）和中风（33.8%）的发生率也将增加最大。由于这些因素，CAD 盛行率的上升预计将推动药物涂层球囊市场的发展。

门诊手术中心的增加预计也将推动药物涂层球囊市场的成长。门诊手术中心 (ASC) 是专门执行无需住院过夜的手术的医疗机构。药物涂层球囊在 ASC 中发挥重要作用，因为与标准球囊相比，它们可以缩短手术时间。 2023 年 9 月，VMG Health 报告称，经 Medicare 认证的门诊手术中心总数将从 2021 年的 1,752 家增加 2.9% 至 2022 年的 1,804 家。基于这些原因，门诊手术中心的日益普及也推动了药物涂层球囊市场的扩大。

本报告调查了全球药物涂层球囊市场，并总结了市场概况和特点、主要趋势、市场影响因素分析、市场规模趋势和预测、各个细分市场、地区/主要国家的详细分析、竞争格局以及主要企业的概况。

目录

第一章执行摘要

第二章 药物涂层球囊市场：特点

第三章 药物涂装球囊市场：趋势与策略

第 4 章。

第五章全球药物涂层球囊市场：成长分析与策略分析框架

  • PESTEL 分析：成长推进因素/阻碍要素
  • 最终用户产业分析
  • 市场成长分析
  • 市场规模趋势和成长率
  • 市场规模成长预测
  • 总潜在市场 (TAM)

6. 药物涂层球囊市场细分

  • 市场规模趋势与预测：按产品
  • 用于治疗周边动脉疾病的药物涂层球囊
  • 用于 CAD 的药物涂层球囊
  • 药物涂层球囊的其他适应症
  • 市场规模趋势及预测：依药物类型
  • 紫杉醇
  • Sirolimus
  • 市场规模趋势与预测：按最终用户
  • 医院
  • 心导管实验室
  • 门诊手术中心
  • 市场规模趋势与预测：周边动脉疾病药物涂层球囊依亚型分类
  • 紫杉醇涂层球囊
  • Sirolimus涂层球囊
  • 市场规模趋势与预测：CAD 药物涂层球囊依亚型划分
  • 紫杉醇涂层球囊
  • Sirolimus涂层球囊
  • Everolimus涂层球囊
  • 市场规模趋势及预测：其他适应症药物涂层球囊依亚型划分
  • 药物涂层球囊治疗股腘动脉损伤
  • 用于治疗肾动脉病变的药物涂层球囊
  • 用于其他血管应用的药物涂层球囊

7. 药物涂层球囊市场：区域与国家分析

  • 市场规模趋势与预测：按地区
  • 市场规模趋势与预测：依国家

8. 亚太地区药物涂层球囊市场

9. 中国药物涂层球囊市场

第十章印度药物涂层气球市场

第十一章 日本药物涂层球囊市场

12. 澳洲药物涂层球囊市场

13. 印尼药物涂层球囊市场

第十四章 韩国药物涂装球囊市场

15.西欧药物涂层球囊市场

第十六章英国药物涂层球囊市场

17. 德国药物涂层球囊市场

18. 法国药物涂层球囊市场

19. 义大利药物涂层气球市场

20.西班牙药用涂层球囊市场

21. 东欧药物涂层球囊市场

22. 俄罗斯药物涂层气球市场

23. 北美药物涂层球囊市场

第24章美国药物涂层球囊市场

25. 加拿大药物涂层球囊市场

26.南美洲药物涂层气球市场

27. 巴西药物涂层球囊市场

28. 中东药物涂层气球市场

29. 非洲药物涂层气球市场

第 30 章药物涂层球囊市场：竞争格局与公司概况

  • 竞争格局
  • 公司简介
    • Acotec Scientific AG
    • B. Braun Melsungen AG
    • Biosensors International Group Ltd
    • Medtronic Inc.
    • Boston Scientific Corporation

第 31 章 药物涂层球囊市场：其他领先与创新企业

  • Opto Circuits
  • Concept Medical
  • Cardionovum GmbH
  • Endocor GmbH
  • Hexacath Sverige
  • iVascular SLU
  • Minvasys SAS
  • MedAlliance
  • QT Vascular Ltd
  • Terumo Corporation
  • Biotronik
  • Cook Medical
  • Cordis Corporation
  • Abbott Laboratories
  • Surmodics Inc.

第 32 章 全球药物涂层球囊市场：竞争基准化分析与仪表板

第 33 章 药物涂层球囊市场：主要併购

第 34 章 药物涂层球囊市场：最新趋势

第 35 章药物涂层球囊市场：潜在国家、细分市场与策略

  • 提供最多新机会的国家
  • 提供最新机会的市场区隔
  • 成长策略

第 36 章 附录

简介目录
Product Code: r24098

A drug-coated balloon (DCB) is a medical device employed in the intervention of narrowed or obstructed blood vessels, particularly in interventional cardiology and interventional radiology. Its design facilitates the direct delivery of medication to the site of vascular disease while concurrently performing angioplasty.

The primary categories of products encompassed within drug-coated balloons include those tailored for peripheral artery disease, coronary artery disease, and other indications. Drug-coated balloons (DCBs) for peripheral artery disease are a specific type of medical device utilized in addressing peripheral artery disease (PAD). PAD is characterized by the narrowing or blockage of blood vessels outside the heart or in the lower extremities. Various drug types, such as paclitaxel and sirolimus, are employed, and the end-users encompass hospitals, cardiac catheterization labs, and ambulatory surgical centers.

The drug-coated balloons market research report is one of a series of new reports from The Business Research Company that provides drug-coated balloons market statistics, including drug-coated balloons industry global market size, regional shares, competitors with a drug-coated balloons market share, detailed drug-coated balloons market segments, market trends and opportunities, and any further data you may need to thrive in the drug-coated balloons industry. This drug-coated balloons market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug-coated balloons market size has grown rapidly in recent years. It will grow from$1.08 billion in 2024 to $1.24 billion in 2025 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to increased cardiovascular disease burden, demand for minimally invasive procedures, prevalence of peripheral artery disease (pad), reducing restenosis rates, advancements in interventional cardiology

The drug-coated balloons market size is expected to see rapid growth in the next few years. It will grow to $2.22 billion in 2029 at a compound annual growth rate (CAGR) of 15.6%. The growth in the forecast period can be attributed to increasing aging population, expansion of indications and applications, focus on outpatient and ambulatory care, integration with drug delivery innovations, global health initiatives. Major trends in the forecast period include regulatory approvals for new formulations, focus on minimizing side effects, emergence of bioresorbable coatings, market expansion in emerging economies, patient-centric approaches.

The increasing prevalence of coronary artery disease (CAD) is projected to drive the growth of the drug-coated balloons market in the future. CAD is a medical condition characterized by the narrowing or blockage of the coronary arteries that supply blood to the heart muscle, often leading to heart attacks. Drug-coated balloons are medical devices used to treat coronary artery disease, releasing medication into the artery during the procedure to help prevent restenosis, which is the re-narrowing of the artery following angioplasty. For instance, a study published in the Journal of the American College of Cardiology in August 2022 indicated that all four cardiovascular risk factors are expected to rise among the general U.S. population from 2025 to 2060. Diabetes is projected to see the most significant increase at 39.3%, followed by dyslipidemia at 27.6%, hypertension at 25.1%, and obesity at 18.3%. Additionally, the researchers found that rates of heart failure (33.4%) and ischemic heart disease (30.7%) are expected to experience the largest increases, along with heart attacks (16.9%) and strokes (33.8%). Consequently, the rise in coronary artery disease prevalence is anticipated to boost the drug-coated balloon market.

The increasing number of ambulatory surgery centers is anticipated to propel the growth of the drug-coated balloon market. Ambulatory Surgical Centers (ASCs) are medical facilities dedicated to conducting surgical procedures that do not necessitate an overnight hospital stay. Drug-coated balloons play a crucial role in ASCs by offering shorter procedure times compared to standard balloons, resulting in improved patient throughput and reduced operational costs. For instance, VMG Health reported in September 2023 that the total number of Medicare-certified ambulatory surgery centers increased by 2.9% from 1752 in 2021 to 1804 in 2022. Hence, the growing prevalence of ambulatory surgery centers is a driving force behind the drug-coated balloon market's expansion.

Product innovations are emerging as a significant trend in the drug-coated balloon market. Leading companies in this sector are concentrating on developing new technological and innovative solutions to enhance their market position. For example, in August 2022, Becton, Dickinson, and Company (BD), a U.S.-based medical technology firm, initiated the PREVISION first-in-human trial for a peripheral sirolimus drug-coated balloon (DCB). This trial is designed to evaluate the safety and effectiveness of the sirolimus DCB for treating patients with peripheral artery disease, a condition that greatly affects mobility and quality of life.

Leading companies in the drug-coated balloon sector are dedicated to advancing their technologies, including paclitaxel-coated balloon catheters, to improve treatment efficacy for conditions such as coronary in-stent restenosis. These advancements aim to enhance patient outcomes and minimize the risk of complications associated with traditional therapies. Paclitaxel-coated balloon catheters are specialized devices that release the drug paclitaxel into the artery wall upon inflation, helping to prevent re-narrowing after angioplasty. For instance, in March 2024, Boston Scientific Corporation, a U.S.-based medical device manufacturer, received approval from the U.S. Food and Drug Administration (FDA) for its AGENT(TM) Drug-Coated Balloon (DCB). This device is designed specifically for treating coronary in-stent restenosis (ISR) in patients with coronary artery disease, which occurs when a previously stented blood vessel becomes obstructed or narrowed due to plaque or scar tissue.

In November 2022, Cordis, a US-based manufacturer of interventional cardiovascular technologies, completed the acquisition of Med Alliance SA for $1.1 billion. Through this acquisition, Cordis aims to globally provide the drug-eluting balloon SELUTION SLRTM (Sustained Limus Release) to two million patients by 2027. Med Alliance SA, based in Switzerland, is a developer of the sirolimus micro-reservoir drug-coated balloon.

Major companies operating in the drug-coated balloons market include Acotec Scientific AG, B. Braun Melsungen AG, Biosensors International Group Ltd, Medtronic Inc., Boston Scientific Corporation, Opto Circuits, Concept Medical, Cardionovum GmbH, Endocor GmbH, Hexacath Sverige, iVascular SLU, Minvasys SAS, MedAlliance, QT Vascular Ltd, Terumo Corporation, Biotronik, Cook Medical, Cordis Corporation, Abbott Laboratories, Surmodics Inc., Hexacath SAS, MicroPort, SurModics Inc., Orchestra BioMed

North America was the largest region in the global drug-coated balloons market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the drug-coated balloons market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The drug-coated balloons market consists of sales of everolimus and zotarolimus drug-coated balloons. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug-Coated Balloons Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug-coated balloons market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug-coated balloons ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug-coated balloons market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Drug-Coated Balloons For Peripheral Artery Disease; Drug-Coated Balloons For Coronary Artery Disease; Drug-Coated Balloons For Other Indications
  • 2) By Drug Type: Paclitaxel; Sirolimus
  • 3) By End User: Hospitals; Cardiac Catheterization Labs; Ambulatory Surgical Centers
  • Subsegments:
  • 1) By Drug-Coated Balloons For Peripheral Artery Disease: Paclitaxel-Coated Balloons; Sirolimus-Coated Balloons
  • 2) By Drug-Coated Balloons For Coronary Artery Disease: Paclitaxel-Coated Balloons; Sirolimus-Coated Balloons; Everolimus-Coated Balloons
  • 3) By Drug-Coated Balloons For Other Indications: Drug-Coated Balloons For Femoropopliteal Lesions; Drug-Coated Balloons For Renal Artery Lesions; Drug-Coated Balloons For Other Vascular Applications
  • Companies Mentioned: Acotec Scientific AG; B. Braun Melsungen AG; Biosensors International Group Ltd; Medtronic Inc.; Boston Scientific Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug-Coated Balloons Market Characteristics

3. Drug-Coated Balloons Market Trends And Strategies

4. Drug-Coated Balloons Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Drug-Coated Balloons Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Drug-Coated Balloons PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Drug-Coated Balloons Market Growth Rate Analysis
  • 5.4. Global Drug-Coated Balloons Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Drug-Coated Balloons Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Drug-Coated Balloons Total Addressable Market (TAM)

6. Drug-Coated Balloons Market Segmentation

  • 6.1. Global Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug-Coated Balloons For Peripheral Artery Disease
  • Drug-Coated Balloons For Coronary Artery Disease
  • Drug-Coated Balloons For Other Indications
  • 6.2. Global Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Paclitaxel
  • Sirolimus
  • 6.3. Global Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Cardiac Catheterization Labs
  • Ambulatory Surgical Centers
  • 6.4. Global Drug-Coated Balloons Market, Sub-Segmentation Of Drug-Coated Balloons For Peripheral Artery Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Paclitaxel-Coated Balloons
  • Sirolimus-Coated Balloons
  • 6.5. Global Drug-Coated Balloons Market, Sub-Segmentation Of Drug-Coated Balloons For Coronary Artery Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Paclitaxel-Coated Balloons
  • Sirolimus-Coated Balloons
  • Everolimus-Coated Balloons
  • 6.6. Global Drug-Coated Balloons Market, Sub-Segmentation Of Drug-Coated Balloons For Other Indications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug-Coated Balloons For Femoropopliteal Lesions
  • Drug-Coated Balloons For Renal Artery Lesions
  • Drug-Coated Balloons For Other Vascular Applications

7. Drug-Coated Balloons Market Regional And Country Analysis

  • 7.1. Global Drug-Coated Balloons Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Drug-Coated Balloons Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug-Coated Balloons Market

  • 8.1. Asia-Pacific Drug-Coated Balloons Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug-Coated Balloons Market

  • 9.1. China Drug-Coated Balloons Market Overview
  • 9.2. China Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug-Coated Balloons Market

  • 10.1. India Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug-Coated Balloons Market

  • 11.1. Japan Drug-Coated Balloons Market Overview
  • 11.2. Japan Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug-Coated Balloons Market

  • 12.1. Australia Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug-Coated Balloons Market

  • 13.1. Indonesia Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug-Coated Balloons Market

  • 14.1. South Korea Drug-Coated Balloons Market Overview
  • 14.2. South Korea Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug-Coated Balloons Market

  • 15.1. Western Europe Drug-Coated Balloons Market Overview
  • 15.2. Western Europe Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug-Coated Balloons Market

  • 16.1. UK Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug-Coated Balloons Market

  • 17.1. Germany Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug-Coated Balloons Market

  • 18.1. France Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug-Coated Balloons Market

  • 19.1. Italy Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug-Coated Balloons Market

  • 20.1. Spain Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug-Coated Balloons Market

  • 21.1. Eastern Europe Drug-Coated Balloons Market Overview
  • 21.2. Eastern Europe Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug-Coated Balloons Market

  • 22.1. Russia Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug-Coated Balloons Market

  • 23.1. North America Drug-Coated Balloons Market Overview
  • 23.2. North America Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug-Coated Balloons Market

  • 24.1. USA Drug-Coated Balloons Market Overview
  • 24.2. USA Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug-Coated Balloons Market

  • 25.1. Canada Drug-Coated Balloons Market Overview
  • 25.2. Canada Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug-Coated Balloons Market

  • 26.1. South America Drug-Coated Balloons Market Overview
  • 26.2. South America Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug-Coated Balloons Market

  • 27.1. Brazil Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug-Coated Balloons Market

  • 28.1. Middle East Drug-Coated Balloons Market Overview
  • 28.2. Middle East Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug-Coated Balloons Market

  • 29.1. Africa Drug-Coated Balloons Market Overview
  • 29.2. Africa Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug-Coated Balloons Market Competitive Landscape And Company Profiles

  • 30.1. Drug-Coated Balloons Market Competitive Landscape
  • 30.2. Drug-Coated Balloons Market Company Profiles
    • 30.2.1. Acotec Scientific AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Biosensors International Group Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Medtronic Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Drug-Coated Balloons Market Other Major And Innovative Companies

  • 31.1. Opto Circuits
  • 31.2. Concept Medical
  • 31.3. Cardionovum GmbH
  • 31.4. Endocor GmbH
  • 31.5. Hexacath Sverige
  • 31.6. iVascular SLU
  • 31.7. Minvasys SAS
  • 31.8. MedAlliance
  • 31.9. QT Vascular Ltd
  • 31.10. Terumo Corporation
  • 31.11. Biotronik
  • 31.12. Cook Medical
  • 31.13. Cordis Corporation
  • 31.14. Abbott Laboratories
  • 31.15. Surmodics Inc.

32. Global Drug-Coated Balloons Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug-Coated Balloons Market

34. Recent Developments In The Drug-Coated Balloons Market

35. Drug-Coated Balloons Market High Potential Countries, Segments and Strategies

  • 35.1 Drug-Coated Balloons Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Drug-Coated Balloons Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Drug-Coated Balloons Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer